Instil Bio (TIL) Non-Current Assets (2020 - 2026)
Instil Bio (TIL) posted quarterly Non-Current Assets of $12.1 million for Q1 2026, down 33.32% year-over-year from $18.2 million in Q1 2025, and little changed quarter-over-quarter from $12.1 million in Q4 2025.
Instil Bio (TIL) Non-Current Assets (2020 - 2026) Analysis & Trends
Instil Bio's Non-Current Assets history runs 7 years deep, the most recent figure standing at $12.1 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 33.32% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $63.3 million (down 85.5% YoY), while the FY2025 annual figure was $12.1 million, down 91.31% from the prior year.
- Non-Current Assets for Q1 2026 stood at $12.1 million, roughly flat from $12.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $219.1 million in Q3 2022, with the low at $12.1 million in Q4 2025.
- The 5-year median for Non-Current Assets is $144.6 million (2023), against an average of $125.7 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 111.49% in 2022, then tumbled 91.31% in 2025.
- Instil Bio's Non-Current Assets stood at $212.8 million in 2022, then slipped by 22.5% to $164.9 million in 2023, then decreased by 15.63% to $139.1 million in 2024, then sank by 91.31% to $12.1 million in 2025, then gained by 0.26% to $12.1 million in 2026.
- Business Quant data shows TIL's Non-Current Assets at $12.1 million in Q1 2026, $12.1 million in Q4 2025, and $15.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | 18.06 Bn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | 126.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126.11 Mn |
| Mar 31, 2026 | 12.13 Mn |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | 15.50 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 18.19 Mn |
| Dec 31, 2024 | 139.10 Mn |
| Sep 30, 2024 | 139.99 Mn |
| Jun 30, 2024 | 139.39 Mn |
| Mar 31, 2024 | 145.27 Mn |
| Dec 31, 2023 | 164.87 Mn |
| Sep 30, 2023 | 144.64 Mn |
| Jun 30, 2023 | 187.72 Mn |
| Mar 31, 2023 | 187.05 Mn |
| Dec 31, 2022 | 212.75 Mn |
| Sep 30, 2022 | 219.09 Mn |
| Jun 30, 2022 | 200.86 Mn |
| Mar 31, 2022 | 174.24 Mn |
| Dec 31, 2021 | 145.96 Mn |
| Sep 30, 2021 | 124.31 Mn |